Margaret Prechel

1.7k total citations
58 papers, 1.4k citations indexed

About

Margaret Prechel is a scholar working on Surgery, Hematology and Internal Medicine. According to data from OpenAlex, Margaret Prechel has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 19 papers in Hematology and 17 papers in Internal Medicine. Recurrent topics in Margaret Prechel's work include Heparin-Induced Thrombocytopenia and Thrombosis (32 papers), Platelet Disorders and Treatments (18 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). Margaret Prechel is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (32 papers), Platelet Disorders and Treatments (18 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). Margaret Prechel collaborates with scholars based in United States, Germany and Japan. Margaret Prechel's co-authors include Jeanine M. Walenga, Mark A. Wright, Matthew R. Young, Yvonne Lozano, Walter Jeske, Janet Benefield, Mamdouh Bakhos, John P. Matthews, Ihtzaz Ahmed Malik and Tapan Audhya and has published in prestigious journals such as Blood, The Journal of Immunology and Brain Research.

In The Last Decade

Margaret Prechel

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret Prechel United States 21 438 408 315 266 221 58 1.4k
Masato Imai Japan 20 204 0.5× 427 1.0× 249 0.8× 15 0.1× 119 0.5× 34 1.7k
Gilles Kauffenstein France 24 135 0.3× 132 0.3× 93 0.3× 55 0.2× 177 0.8× 49 1.4k
Susan I. Ramos United States 14 253 0.6× 161 0.4× 77 0.2× 9 0.0× 75 0.3× 14 1.4k
Francesca L. Sciacca Italy 21 445 1.0× 151 0.4× 513 1.6× 40 0.2× 68 0.3× 48 1.7k
Yasuhiro Kosaka United States 18 170 0.4× 741 1.8× 203 0.6× 38 0.1× 152 0.7× 50 1.8k
Aileen M. Healy United States 13 302 0.7× 156 0.4× 106 0.3× 148 0.6× 429 1.9× 18 1.4k
Noelia A-González Germany 15 1.4k 3.1× 333 0.8× 207 0.7× 11 0.0× 139 0.6× 19 2.1k
Jennifer L. Strande United States 21 70 0.2× 220 0.5× 56 0.2× 27 0.1× 140 0.6× 50 1.3k
Robert R. Rigor United States 15 140 0.3× 102 0.3× 123 0.4× 18 0.1× 29 0.1× 29 1.0k
Fredrik Celsing Sweden 20 384 0.9× 63 0.2× 358 1.1× 9 0.0× 563 2.5× 44 1.8k

Countries citing papers authored by Margaret Prechel

Since Specialization
Citations

This map shows the geographic impact of Margaret Prechel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Prechel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Prechel more than expected).

Fields of papers citing papers by Margaret Prechel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Prechel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Prechel. The network helps show where Margaret Prechel may publish in the future.

Co-authorship network of co-authors of Margaret Prechel

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Prechel. A scholar is included among the top collaborators of Margaret Prechel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Prechel. Margaret Prechel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prechel, Margaret & Jeanine M. Walenga. (2015). Complexes of platelet factor 4 and heparin activate Toll‐like receptor 4. Journal of Thrombosis and Haemostasis. 13(4). 665–670. 8 indexed citations
2.
Prechel, Margaret & Jeanine M. Walenga. (2013). Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia. Thrombosis Journal. 11(1). 7–7. 37 indexed citations
4.
Prechel, Margaret, Walter Jeske, & Jeanine M. Walenga. (2010). Laboratory Methods and Management of Patients with Heparin-Induced Thrombocytopenia. Methods in molecular biology. 663. 133–156. 1 indexed citations
5.
Prechel, Margaret, Walter Jeske, & Jeanine M. Walenga. (2009). Physiological changes in membrane-expressed platelet factor 4: Implications in heparin-induced thrombocytopenia. Thrombosis Research. 125(4). e143–e148. 10 indexed citations
6.
Walenga, Jeanine M., Margaret Prechel, Walter Jeske, et al.. (2008). Rivaroxaban – an oral, direct Factor Xa inhibitor – has potential for the management of patients with heparin‐induced thrombocytopenia. British Journal of Haematology. 143(1). 92–99. 52 indexed citations
7.
Walenga, Jeanine M., Walter Jeske, Margaret Prechel, & Mamdouh Bakhos. (2004). Newer Insights on the Mechanism of Heparin-Induced Thrombocytopenia. Seminars in Thrombosis and Hemostasis. 30. 57–67. 24 indexed citations
8.
Walenga, Jeanine M., Walter Jeske, Margaret Prechel, Peter Bacher, & Mamdouh Bakhos. (2004). Decreased Prevalence of Heparin-Induced Thrombocytopenia with Low-Molecular-Weight Heparin and Related Drugs. Seminars in Thrombosis and Hemostasis. 30. 69–80. 31 indexed citations
9.
Prechel, Margaret, et al.. (2000). In Vivo Indomethacin Treatment Causes Microgial Activation in Adult Mice. Neurochemical Research. 25(3). 357–362. 6 indexed citations
10.
Young, Matthew R., Mark A. Wright, Yvonne Lozano, et al.. (1997). Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. International Journal of Cancer. 74(1). 69–74. 133 indexed citations
11.
Young, Matthew R., Mark A. Wright, Yvonne Lozano, et al.. (1996). Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer. International Journal of Cancer. 67(3). 333–338. 157 indexed citations
12.
Prechel, Margaret. (1996). Increased interleukin-6 production by cerebral cortical tissue of adult versus young mice. Mechanisms of Ageing and Development. 92(2-3). 185–194. 24 indexed citations
15.
Prechel, Margaret, Arthur T. Orawski, Linda Maggiora, & W.H. Simmons. (1995). Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.. Journal of Pharmacology and Experimental Therapeutics. 275(3). 1136–1142. 70 indexed citations
16.
McNulty, John A. & Margaret Prechel. (1992). Circannual Analysis of Pineal Gland Indoles and Vasotocin-Like Immunoreactivity in Male Rats Kept on Constant Photoschedules and Temperature. Neurosignals. 1(3). 150–159. 4 indexed citations
17.
Kus, Laura, et al.. (1990). Magnetic resonance imaging (MRI) effects on rat pineal neuroendocrine function. Brain Research. 506(2). 294–296. 6 indexed citations
18.
McNulty, John A., Margaret Prechel, Louis D. Van de Kar, & Linda M. Fox. (1989). Effects of Isoproterenol on Synaptic Ribbons in Pinealocytes of the Rat and C57BL/6J Mouse. Journal of Pineal Research. 7(3). 305–311. 12 indexed citations
19.
Prechel, Margaret, Tapan Audhya, & William H. Simmons. (1989). Influence of Age on August Levels of Pineal Immunoreactive Arginine Vasotocin in Rats. Journal of Pineal Research. 6(1). 1–7. 10 indexed citations
20.
Prechel, Margaret, Tapan Audhya, Rand S. Swenson, John A. McNulty, & William H. Simmons. (1989). A seasonal pineal peptide rhythm persists in superior cervical ganglionectomized rats. Life Sciences. 44(2). 103–110. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026